Back
GT Biopharma Vs. SoftBank Group Industry Stock Comparison
Sell
49
GTBP
GT Biopharma
Last Price:
2.03
Seasonality Move:
-3.67%
Sell
45
SFTBY
SoftBank Group
Last Price:
29.86
Seasonality Move:
1.61%
Sell
49
GT Biopharma (GTBP)
is a Sell
Is GT Biopharma a Buy, Sell or Hold?
- The current GT Biopharma [GTBP] share price is $2.02. The Score for GTBP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- GTBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
SoftBank Group (SFTBY)
is a Sell
Is SoftBank Group a Buy, Sell or Hold?
- The current SoftBank Group [SFTBY] share price is $29.86. The Score for SFTBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- SFTBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GTBP Stock Price Chart
What is GT Biopharma's stock price today?
-
The GT Biopharma share price today is $2.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTBP is experiencing slight selling pressure.
SFTBY Stock Price Chart
What is SoftBank Group's stock price today?
-
The SoftBank Group share price today is $29.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFTBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
GTBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 42.95 | Sell |
| Chaikin Money Flow: | -11804 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.03 - 2.19) | Sell |
| Bollinger Bands (100): | (1.93 - 3.53) | Sell |
SFTBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 53.06 | Buy |
| Chaikin Money Flow: | 400281 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.84 - 30.42) | Buy |
| Bollinger Bands (100): | (27.1 - 32.74) | Sell |
GTBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.13 | Sell |
| 20-day SMA: | 2.12 | Sell |
| 50-day SMA: | 2.22 | Sell |
| 200-day SMA: | 3.86 | Sell |
| 8-day EMA: | 2.11 | Sell |
| 20-day EMA: | 2.13 | Sell |
| 50-day EMA: | 2.29 | Sell |
| 200-day EMA: | 4.74 | Sell |
SFTBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.89 | Sell |
| 20-day SMA: | 29.58 | Buy |
| 50-day SMA: | 28.51 | Buy |
| 200-day SMA: | 27.85 | Buy |
| 8-day EMA: | 29.75 | Buy |
| 20-day EMA: | 29.52 | Buy |
| 50-day EMA: | 29.38 | Buy |
| 200-day EMA: | 27.81 | Buy |
GT Biopharma Earnings Growth & GTBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.
SoftBank Group Earnings Growth & SFTBY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
GT Biopharma Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SoftBank Group Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||